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Abstract Proteins of the tetraspanin superfamily participate in
the formation of plasma membrane signaling complexes; recent
evidence implicates neuronal tetraspanins in axon growth and
target recognition. We used a degenerate PCR screen to identify
cDNAs encoding tetraspanins expressed in the embryonic spinal
cord. Two cDNAs identified apparently represent chick homo-
logues of NAG-2 (cnag) and CD9 (chCD9). A third clone
encodes a novel tetraspanin (neurospanin). All three mRNAs are
widely expressed but exhibit developmentally distinct patterns of
expression in the nervous system. Both neurospanin and cnag
exhibit high relative expression in nervous tissue, including brain,
spinal cord and dorsal root ganglia (DRG).
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1. Introduction
The tetraspanin superfamily, also known as the tetraspans
or the transmembrane 4 superfamily, is a newly described
family of integral membrane proteins comprising more than
20 members [1]. The tetraspanins are small, 220^280 amino
acid glycoproteins, which share 20^45% sequence identity.
These proteins have been conserved during evolution and
are expressed in a wide variety of eukaryotic species including
human, mouse and Drosophila [2^5].
Although initially identi¢ed as leukocyte surface antigens,
many tetraspanin family members are expressed in a wide
variety of cell types [6,7]. In the adult nervous system, both
central and peripheral glia strongly express the tetraspanin
CD9 [8]. Early in development, CD9 is expressed in restricted
neuronal populations [4,8,9]. Another tetraspanin, the Droso-
phila protein late bloomer (lbl), exhibits an expression pattern
nearly exclusive to a speci¢c subset of motorneurons, with
weak transient expression in some peripheral sensory neurons
[5].
Tetraspanin family members may have roles in the regula-
tion of axon growth. First, CD9 has been localized to neurons
early in development, coincident with a period of active axon
growth for many neuronal populations [4,8]. Second, L1 in-
tegrins are commonly found in complexes with tetraspanins
[10]; these integrins are known to mediate axon growth in-
duced by numerous extracellular matrix proteins [11,12]. En-
hanced integrin-mediated neurite outgrowth in response to
CD9 activation suggests a functional relationship between in-
tegrins and tetraspanins [4,13]. Recent evidence suggests that
tetraspanins may serve as a link between integrin subunits and
various intracellular signaling molecules, such as phosphatidyl-
inositol 4-kinase and PKC [14^16]. Third, tetraspanin activa-
tion can result in increases in intracellular calcium and en-
hanced tyrosine kinase and phosphatase activity [4,17,18],
each of which has been implicated in the regulation of neurite
outgrowth e.g. [19^21].
Tetraspanins may be important in the regulation of motor
axon growth and target recognition [5,8]. To date, only a few
tetraspanins have been shown to be expressed in the develop-
ing vertebrate nervous system, with only CD9 known to be
expressed by developing neurons [13,34,35]. We hypothesized
that speci¢c populations of developing neurons express spe-
ci¢c complements of tetraspanins and that these are involved
in the regulation of axon growth and synapse formation. To
begin to examine this issue for the developing spinal cord, we
screened chick spinal cord mRNA for expression of tetraspa-
nins at embryonic day 6 (E6), a time when motor axons are
actively growing towards and synapsing with their targets
[22,23]. Through this screen, we have identi¢ed and charac-
terized a novel tetraspanin as well as two chick homologues of
previously described mammalian tetraspanins.
2. Materials and methods
2.1. Materials
Fertilized eggs from SPAFAS (Preston, CT, USA) were incubated
at 38‡C until use. Various chick tissues were dissected from the em-
bryos, immediately frozen in liquid nitrogen, and stored at 380‡C
until use. Restriction enzymes used for subcloning were purchased
from New England Biolabs, (Beverly, MA, USA). All other reagents
were from Sigma (St. Louis, MO, USA) unless otherwise noted.
2.2. Reverse transcription-polymerase chain reaction (RT-PCR) assays
Complementary DNA (cDNA) was reverse transcribed from total
RNA isolated from various chick tissues and developmental ages us-
ing the Ultraspec RNA isolation system (Biotecx Laboratories, Hous-
ton, TX, USA). Equivalent aliquots of the cDNA synthesis reactions
were used for each PCR assay. Superscript II reverse transcriptase,
Taq DNA polymerase, and all PCR primers were obtained from Gib-
co-BRL (Grand Island, NY, USA). Random hexamers were pur-
chased from Promega (Madison, WI, USA) and dNTPs were pur-
chased from Stratagene (La Jolla, CA, USA).
2.3. Degenerate PCR screen of E6 spinal cord
RT-PCR assays were carried out on embryonic day 6 (E6) spinal
cord mRNA using degenerate primers designed based on conserved
regions of transmembrane domains 1 and 2 in the following tetraspa-
nins: CD9, CD81, CD82, CD63 and PETA-3. Because of the limited
sequence identity among tetraspanins even in this region, our primers
contained both degeneracy and inosine residues (‘I’ in primer sequen-
ces). The 5P primer corresponded to the sequence at the beginning of
transmembrane domain 1 (5P-AAR TGY III AAR TWY YTI YTI
TW-3P) and the 3P primer corresponded to the sequence at the end of
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transmembrane domain 2 (5P-GC NCC III RCA NCC IAR RAA
ICC-3P).
2.4. Isolation of tetraspanin clones
An E10 chick retinal library [24] and an E13 chick brain library [25]
were screened with tetraspanin DNA fragments, obtained from the
degenerate PCR assay, essentially as described [24]. Probes were 3P-
end labeled as described [26].
Rapid ampli¢cation of cDNA ends (RACE) was performed using
the Marathon cDNA Ampli¢cation kit (Clontech, Palo Alto, CA,
USA). E8 brain mRNA was used to generate an adapter-ligated
cDNA library for the RACE protocol. A 5P cnag RACE product
and a 3P chCD9 RACE product were obtained using standard proto-
cols. Alternative strategies were necessary to obtain the remaining
sequences for cnag and chCD9. The 3P end of cnag was ampli¢ed
from E8 brain cDNA using a primer based on the amino acid se-
quence (AMTMYC) at the 3P end of the fourth transmembrane do-
main of human and mouse NAG-2. Similarly, the 5P end of chCD9
was ampli¢ed from E8 brain cDNA using a primer based on the
completely conserved N-terminal amino acid sequence (MPVKGG)
of several CD9 species homologues.
Dideoxy sequencing of clones was performed as described [24].
Sequences were also obtained from the University of Miami DNA
Core Lab Sequencing Service. Sequence analysis was performed using
the Genetics Computer Group (GCG) sequence analysis software
(Madison, WI, USA).
2.5. Northern blotting
Total RNA or poly A mRNA, isolated from total RNA using the
Poly A-Tract mRNA isolation system (Promega, Madison, WI,
USA), was separated on formaldehyde gels, transferred to nitrocellu-
lose membranes and hybridized with full-length tetraspanin cDNA
clones as described [24]. After exposure to ¢lm, membranes were
stripped and re-probed with a random primer-labeled, 1.8 kb frag-
ment of chick L-actin [25]. Intensity measurements of hybridization
signals were obtained using SigmaScan Pro3 software from Jandel
Scienti¢c (San Rafael, CA, USA). Relative tetraspanin expression
levels were obtained by normalization to L-actin levels.
2.6. In situ hybridization
Lumbar spinal cords from E8 chick embryos were dissected and
treated exactly as described [27]. Sense and antisense probes were
generated, using SP6 polymerase, from the full length neurospanin
cDNA cloned into pSP73 and pSP72, respectively (Promega, Madi-
son, WI, USA). Slides were exposed for 4^6 weeks at 4‡C in the dark
with desiccator. Following development of the autoradiographic
emulsion, sections were counterstained with 0.02% toluidine blue
and coverslipped for analysis.
3. Results
3.1. Cloning of three tetraspanins expressed in the embryonic
spinal cord
The expression pattern of CD9 in the mammalian nervous
system, together with the discovery of lbl in the £y [5,8,28], led
us to hypothesize that a number of tetraspanins would be
expressed in cell populations of the embryonic brain and spi-
nal cord. To examine the tetraspanins expressed in the devel-
oping spinal cord, we performed a degenerate PCR screen of
E6 chick spinal cord mRNA, using primers complementary to
conserved regions in tetraspanin transmembrane domains 1
and 2. Sequence analysis of 42 clones revealed 5 putative
Fig. 1. Amino acid sequences of neurospanin, cnag, and chCD9. Black boxes in the ¢gure indicate identical residues. Dashed lines indicate the
putative transmembrane domains. Asterisks denote the four conserved cysteines found in the large extracellular domains of tetraspanin family
members. The novel tetraspanin, neurospanin, shares up to 32% identity with other tetraspanin superfamily members. The cnag sequence shares
86% identity with human and mouse NAG-2 and chCD9 shares 70% to 74% amino acid identity with known mammalian CD9 isoforms. The
DNA sequences for neurospanin, cnag and chCD9 have the GenBank accession numbers XX, YY and ZZ, respectively.
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tetraspanin clones, identi¢ed on the basis of signi¢cant se-
quence identity to known tetraspanins. Two clones were iden-
ti¢ed twice and were tentatively identi¢ed as the chick ortho-
logues of previously identi¢ed tetraspanins, NAG-2 and CD9.
Sequence obtained for a ¢fth clone apparently represented a
novel tetraspanin. Because it was cloned from nervous tissue,
we have named this novel clone neurospanin. Full-length se-
quences for neurospanin, cnag and chCD9 were obtained by a
combination of RT-PCR, screening of cDNA libraries [24,25],
and RACE protocols (Fig. 1).
3.2. Embryonic tissue distribution of neurospanin and cnag
mRNA expression
We examined the expression of neurospani, cnag, and
chCD9 in various E8 chick tissues (spinal cord, brain, heart,
skeletal muscle, liver, skin, intestine and gizzard) by RT-PCR;
mRNAs encoding all three tetraspanins are widely expressed
in the chick embryo (data not shown). Relative levels of neu-
rospanin mRNA in various E8 tissues were examined by
Northern blot analysis (Fig. 2A). The highest level of neuro-
spanin mRNA in the E8 embryo was detected in the brain,
with high levels also in the heart. Moderate levels of neuro-
spanin mRNA were found in the spinal cord, intestine, and
gizzard, with low levels in skeletal muscle, liver, and skin.
Relative expression levels of cnag mRNA in various regions
of the embryonic nervous system were also examined (Fig.
2B). Expression of cnag mRNA in embryonic brain was low
relative to the spinal cord, and levels in forebrain were lower
than in total brain. These data suggest a rostro-caudal gra-
dient of expression for cnag, with lowest levels in the rostral
brain. Relatively high levels of cnag mRNA were also de-
tected in the peripheral dorsal root ganglia (DRG) at E9.
3.3. Developmental expression of neurospanin, cnag and chCD9
in chick brain
We also examined the developmental pattern of expression
for neurospanin cnag, and chCD9 mRNAs in chick brain.
Neurospanin mRNA was expressed in E5 brain and expres-
sion levels increased 7-fold between E5 and E10 (Fig. 3A).
Neurospanin mRNA expression remained roughly constant
from E10 until about E17, then increased about two-fold to-
ward the end of embryogenesis. Levels of cnag mRNA in
brain increased gradually throughout embryonic development
and were highest at the time of hatching (Fig. 3B). The ex-
pression of chCD9 mRNA is evidently very low in whole
brain and was not detected using total RNA. Northern blots
using poly A-selected mRNA revealed that brain levels of
chCD9 mRNA increased dramatically (s 300-fold) between
E14 and hatching (Fig. 3C). Previous studies have shown
that mammalian CD9 is expressed in restricted neuronal pop-
ulations at early developmental ages [4,8]. Similar restricted
expression of chCD9 in speci¢c populations of neurons in the
chick brain could explain the low levels of expression we
detected at early developmental stages.
3.4. In situ hybridization analysis of neurospanin expression in
the embryonic spinal cord
We used in situ hybridization to examine the distribution of
neurospanin mRNA expression in the E8 spinal cord. Expres-
sion was observed in portions of the dorsal horn throughout
the lumbosacral enlargement (Fig. 4BB). In the dorsal horn,
strongest expression was observed at more rostral and caudal
aspects of the enlargement (Fig. 4B and F(high)), with weaker
expression in intervening segments (data not shown and Fig.
4F(avg)). Expression appeared con¢ned to laminae 2 and 3 of
the dorsal horn [29] ; in central segments of the enlargement
expression was mainly in lamina 2 (data not shown). Hybrid-
ization signals could be seen on large cells (presumptive neu-
rons) ; we could not determine whether glia also expressed
neurospanin. No expression was detected in the ventral por-
tion of the spinal cord, including the motor columns. Neuro-
spanin mRNA expression was also found in the dorsal root
ganglia of the lumbosacral region (Fig. 4E), but no di¡erential
pattern of rostral-caudal expression was detected, as evi-
denced by a single population of hybridization grain density
(Fig. 4G).
4. Discussion
Several lines of evidence suggest that tetraspanins play roles
in axonal growth and guidance processes. First, two tetraspa-
nin family members, CD9 and lbl, have been localized to the
nervous system, exhibiting restricted expression in subpopula-
Fig. 2. A: Northern blot analysis of neurospanin expression in vari-
ous embryonic chick tissues including E8 chick spinal cord (SC),
brain (Br), heart (Ht), skeletal muscle (Mu), liver (Li), skin (Sk), in-
testine (In) and gizzard (Gz). B: Northern blot analysis of cnag ex-
pression in various embryonic neuronal populations including E8
spinal cord (SC), E8 brain (Br), E7 forebrain (Fb) and E9 dorsal
root ganglia (DRG). 25 Wg of total RNA, isolated from the indi-
cated tissues, was probed with a full length neurospanin (A) or
cnag (B) cDNA (upper panels), and re-probed with a random pri-
mer-labeled 1.8 kb cDNA fragment of chick L-actin as a loading
control (lower panels).
Fig. 3. Northern blot analysis of neurospanin, cnag, and chCD9 ex-
pression in the developing chick brain. (A,B) 40 Wg of total RNA
or (C) 5 Wg of poly A mRNA was isolated from brain at the indi-
cated embryonic ages and probed with a full length neurospanin
(A), cnag (B), or chCD9 (C) cDNA (upper panels). The blots were
re-probed with a L-actin cDNA probe as a loading control (lower
panels). The neurospanin, cnag and chCD9 transcripts are expressed
as 3.4 kb, 5.3 kb, and 1.1 kb mRNAs, respectively. A shorter tran-
script was not detected in the cnag blot at 1.5 kb, as has been re-
ported for NAG-2 in various adult human tissues [7].
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tions of motorneurons early in development [4,5,8]. Second,
tetraspanins are known to form complexes with axonal
growth-promoting proteins, such as integrins and cell adhe-
sion molecules [4,6,10,14,15]. Third, antibody stimulation of
tetraspanins results in calcium mobilization and tyrosine
phosphorylation events [1], which are important features of
signal transduction mechanisms regulating neurite outgrowth
[4,20,21]. Finally, functional studies have implicated CD9 and
lbl in axon growth and target recognition [4,5,13]. Taken to-
gether, the data suggest that neuronally expressed tetraspanins
could function as facilitators of neurite outgrowth-dependent
signal transduction through their association with growth pro-
moting molecules.
In attempts to identify neurally-expressed tetraspanins, we
cloned a cDNA encoding a novel tetraspanin, neurospanin.
Although widely expressed in the embryo, neurospanin
mRNA was found at highest levels in the developing brain.
Further, neurospanin mRNA is upregulated in brain during
the peak time of axon growth [30^33]. Expression of neuro-
spanin in both the DRG and the dorsal horn was observed at
embryonic day 8, a time when lumbosacral sensory a¡erents
are forming synapses with their central targets [32,33]. Our
data suggest that neurospanin may play an important role
in early processes relevant to the development of the nervous
system, perhaps in neuron-neuron interactions in the develop-
ing spinal cord.
We have identi¢ed a neuronally expressed chick tetraspanin
that is highly similar to mammalian CD9. As mentioned, the
sequence identity shared between the putative chick CD9 ho-
mologue and mammalian CD9 isoforms is relatively low.
Mammalian CD9 isoforms share 84% to 99% sequence iden-
tity across species, whereas the putative chick CD9 homo-
logue shares only 70% to 74% identity with mammalian
CD9 isoforms. In contrast, the chick NAG-2 homologue
shares 86% identity with the human and mouse NAG-2 iso-
forms. Our chick CD9 clone is su⁄ciently di¡erent from the
known CD9 isoforms, especially in the large extracellular
loop, to suggest that chCD9 may be a CD9 splice variant
or a related gene product. Alternative splicing of the CD9
gene has been proposed [9].
The demonstration of cnag expression in chick brain ap-
pears to contradict the report on mammalian NAG-2 [7]. One
obvious di¡erence between the latter study and our own is the
age of the tissue samples (adult vs. embryonic). However, the
levels of cnag mRNA increased during embryonic develop-
ment, with the highest levels associated with the day of hatch-
ing. This ¢nding suggests continued expression in the adult
animal. A more likely explanation is suggested by the low
levels of cnag mRNA in brain compared to spinal cord and
peripheral ganglia; expression in brain could simply be below
the level of detection in the earlier study [7]. It is also con-
ceivable that cnag is not the ortholog of mammalian NAG-2,
despite the close sequence similarity.
DRGs express at least three di¡erent tetraspanin family
members: neurospanin, cnag, and CD9 (present study;
[8,28]). Indeed, it is possible that a number of tetraspanins
are expressed in DRGs, as well as other populations of neu-
rons throughout the developing nervous system. Thus expres-
sion of particular complements of tetraspanins in neurons
could support the assembly of multimolecular signaling com-
plexes with proteins that in£uence the growth and guidance of
axons, such as L1 integrins and cell adhesion molecules, reg-
ulating the formation of speci¢c sensory connections in the
spinal cord.
Fig. 4. In situ hybridization analysis of neurospanin mRNA in the embryonic chick spinal cord and DRG. A: Transverse section of E8 lumbar
spinal cord. The black box represents area enlarged in panels B and C. B,C: Phase-contrast images of E8 dorsal horn hybridized with an anti-
sense (B) or sense (C) neurospanin cRNA probe. Panel B represents those sections that exhibited stronger hybridization signals commonly
found at more rostral and caudal aspects of the lumbar spinal cord. In panels A^C, arrowheads delineate the border between white and gray
matter and arrows indicate the end of the speci¢c hybridization band, approximately laminae 2 and 3 of the dorsal horn [29]. D: Transverse
section of E8 lumbar DRG. The nerve root is indicated by the arrow and the ganglion is outlined by arrowheads. E,F: Phase-contrast images
of E8 DRG hybridized with an antisense (E) neurospanin cRNA probe. F,G: Quantitative data for hybridization grain densities in the dorsal
horn (F) and DRGs (G) of the lumbosacral spinal cord. Bar in A, 100 Wm for A and D. Bar in C, 10 Wm for B, C and E.
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